WHILE bacteria are rapidly evolving resistance to life-saving antibiotics, drug companies and governments have made little effort to develop new ones. Now the US government is finally stepping in to try to fill the gap.
Both houses of Congress are looking at the Strategies to Address Antimicrobial Resistance (STAAR) bill, which calls for $230 million of funding over the next three years to set up a dedicated federal office to oversee the problem, with the help of scientists from the US and abroad.
The office would run a network of 10 or more labs in the US monitoring the emergence…
